Gland Pharma Ltd. has raised Rs 1,944 crore from anchor investors ahead of its initial public offering.
The IPO committee of the board “finalised allocation of 1,29,59,089 equity shares in aggregate, to anchor investors at the anchor investor allocation price of Rs 1,500 per equity share”, the company informed stock exchanges.
At this price, the company garnered Rs 1,944 crore.
The anchor investors include Government of Singapore, Nomura, Goldman Sachs, Morgan Stanley, SBI Mutual Fund, Axis Mutual Fund, SBI Life Insurance Co., Fidelity, ICICI Prudential Mutual Fund, HSBC Global Investment Funds, Small Cap World Fund and The Scottish Oriental Smaller Companies Trust PLC among others.
The Hyderabad-based company, backed by China’s Fosun Pharma, develops, manufactures and markets complex injectables.
The company has fixed a price of Rs 1,490-1,500 per share for the initial public offer,…
